Latka logo
Refoxy Pharma logo

Refoxy Pharmarevenue

Cologne, North Rhine-Westphalia, GermanyFounded 2020CEO Henrik Shimony

Refoxy Pharma is a pre-clinical stage biotechnology company developing medicines for the treatment and prevention of aging and aging-associated diseases.

refoxy.comLinkedInUpdated Sep 10, 2026
Annual revenue
$23.1M
Sep 2025EST
Employees
11
Sep 2025

Refoxy Pharma revenue

Refoxy Pharma has not published its revenue. Growjo puts it at about $23.1M a year (September 2025).

$0
$10M
$20M
$0
–
$23.1M
20202021–242025
ReportedEstimateFounded 2020 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$23.1MESTGrowjo estimate

Refoxy Pharma CEO & employees

Henrik Shimony is CEO of Refoxy Pharma. Refoxy Pharma has 11 employees (September 2025, LinkedIn).

0
5
10
11
2025
ReportedOne figure per year; a reported figure wins over an estimate

Refoxy Pharma FAQ

What is Refoxy Pharma's revenue?

Growjo estimates Refoxy Pharma's revenue at about $23.1M a year (September 2025). The company hasn't published its own figure.

How many employees does Refoxy Pharma have?

Refoxy Pharma has 11 employees as of September 2025, according to LinkedIn.

Who is the CEO of Refoxy Pharma?

Henrik Shimony is the CEO of Refoxy Pharma.

Categories

Companies in

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Refoxy Pharma? Join the podcast